The European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) announced plans to hold new monthly drug safety teleconferences to discuss drug safety issues that impact both agencies.
The conversations will focus on information exchange rather than policy development. Teleconferences will be attended by 5 or 6 EMA staff members, and the same number of FDA employees, as well as members of the Pharmacovigilance Risk Assessment Committee (PRAC), established in Europe in 2012.
Click here to read more.
The OMS, Ltd. is a nationally recognized team of physicians and medical specialists who work closely with other occupational health and safety professionals. To find out more click here or call us at (800) 359-1979.